Screener
Inhibrx Biosciences, Inc. INBX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | MARCH 31, 2026 | DECEMBER 31, 2025 |
|---|---|---|
| Property and equipment, net | 3,196 | 3,733 |
| Operating right-of-use asset | 5,052 | 5,535 |
| Other non-current assets | 4,378 | 4,378 |
| Total assets | $183,967 | $146,478 |
| Liabilities and stockholders’ equity (deficit) | ||
| Current liabilities: | ||
| Accounts payable | $8,762 | $5,944 |
| Accrued expenses | 15,342 | 25,529 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s total assets?
- Inhibrx Biosciences, Inc. (INBX) reported total assets of $183.97M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s total assets changed year-over-year?
- Inhibrx Biosciences, Inc.'s total assets decreased by 24.2% year-over-year, from $242.64M to $183.97M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total assets?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s total assets has grown at a -31.0% compound annual growth rate (CAGR), from $307.89M to $146.48M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Inhibrx Biosciences, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude